Taixing Borui Biopharmaceutical
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- Undisclosed
Investors
- 1
About Taixing Borui Biopharmaceutical
, trading as Taixing Borui Biopharmaceutical, is an active pharmaceutical ingredient (API) manufacturer and R&D company dedicated to the production and research of APIs for innovative drugs. The company’s business scope includes biological APIs (such as Neomocontin, Acarbose, Vancomycin, Epomycin, DAPTOmycin, S-adenosylmethionine, Ascaridin, Sirolimus, Fidamirin, Caspofungin, Micafungin, Anifungin, and Pimecrolimus). The company’s revenue is generated by providing biological APIs drugs.
Who invested in Taixing Borui Biopharmaceutical
1 investor across 1 round
See all investors in Taixing Borui Biopharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 12, 2026
Amount
Undisclosed
Investors
Questions about Taixing Borui Biopharmaceutical
Who invested in Taixing Borui Biopharmaceutical?
Taixing Borui Biopharmaceutical has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Taixing Borui Biopharmaceutical raised?
Taixing Borui Biopharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Taixing Borui Biopharmaceutical last raise money?
Taixing Borui Biopharmaceutical's most recent round on record is a Series A, in Mar 2026.
What does Taixing Borui Biopharmaceutical do?
, trading as Taixing Borui Biopharmaceutical, is an active pharmaceutical ingredient (API) manufacturer and R&D company dedicated to the production and research of APIs for innovative drugs.
Where is Taixing Borui Biopharmaceutical headquartered?
Taixing Borui Biopharmaceutical is headquartered in Taixing, China.
Which VCs invest in companies like Taixing Borui Biopharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Taixing Borui Biopharmaceutical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Taixing Borui Biopharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.